Definitive Healthcare Corp. - Laporan Laba Rugi (TTM)

Definitive Healthcare Corp.
US ˙ NasdaqGS ˙ US24477E1038

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Definitive Healthcare Corp. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 118 128 140 153 166 179 194 208 223 232 238 246 251 256 258 256 252 248 245
Change (%) 8.15 9.79 9.26 8.24 7.94 8.21 7.37 6.86 4.08 2.77 3.34 2.17 1.70 1.09 -1.02 -1.42 -1.70 -1.20
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 11 13 15 17 19 21 23 24 26 28 30 32 35 36 38 39 41 41 40
Change (%) 14.14 15.34 17.20 13.55 9.03 7.69 6.31 6.69 10.06 6.60 6.90 7.08 3.41 5.08 3.75 3.88 1.00 -2.69
% of Revenue 9.37 9.89 10.39 11.14 11.69 11.81 11.75 11.63 11.62 12.28 12.74 13.18 13.82 14.05 14.60 15.31 16.13 16.57 16.33
Gross Operating Profit 107 115 126 136 147 158 171 184 197 203 208 214 217 220 221 217 212 207 205
Change (%) 7.53 9.18 8.34 7.58 7.79 8.28 7.51 6.88 3.29 2.23 2.81 1.42 1.43 0.43 -1.83 -2.38 -2.22 -0.91
% of Revenue 90.63 90.11 89.61 88.86 88.31 88.19 88.25 88.37 88.38 87.72 87.26 86.82 86.18 85.95 85.40 84.69 83.87 83.43 83.67
SG&A 49 53 62 74 89 105 120 133 141 146 151 153 153 155 150 144 133 127 126
Change (%) 9.30 16.63 18.41 21.42 17.87 13.67 11.10 6.24 3.67 3.23 1.20 0.35 0.74 -2.78 -3.90 -7.82 -4.30 -0.73
% of Revenue 41.16 41.60 44.19 47.89 53.72 58.66 61.62 63.76 63.39 63.14 63.43 62.12 61.01 60.44 58.12 56.43 52.76 51.37 51.62
R&D 11 12 14 16 19 22 26 31 35 38 39 41 42 43 43 39 37 36 34
Change (%) 11.93 14.56 15.00 13.80 16.46 20.48 17.12 14.36 8.70 4.02 3.94 3.51 0.58 -0.25 -8.17 -6.62 -2.28 -6.04
% of Revenue 9.35 9.68 10.10 10.63 11.17 12.06 13.42 14.64 15.67 16.37 16.56 16.66 16.88 16.70 16.47 15.28 14.48 14.39 13.69
OpEx 130 138 151 167 187 209 230 247 259 267 272 278 282 285 282 274 262 257 254
Change (%) 5.67 9.29 10.80 12.15 11.39 10.22 7.51 4.75 3.29 1.92 1.94 1.65 0.82 -0.90 -2.80 -4.46 -1.91 -1.03
% of Revenue 110.24 107.71 107.21 108.73 112.66 116.26 118.42 118.57 116.24 115.35 114.41 112.87 112.29 111.32 109.13 107.16 103.86 103.64 103.82
Operating Income -12 -10 -10 -13 -21 -29 -36 -39 -36 -36 -34 -32 -31 -29 -24 -18 -10 -9 -9
Change (%) -18.53 2.73 32.19 56.95 38.69 22.56 8.26 -6.58 -1.59 -3.57 -7.71 -2.38 -6.36 -18.49 -22.31 -46.86 -7.44 3.87
% of Revenue -10.24 -7.71 -7.21 -8.73 -12.66 -16.26 -18.42 -18.57 -16.24 -15.35 -14.41 -12.87 -12.29 -11.32 -9.13 -7.16 -3.86 -3.64 -3.82
Interest Expense -36 -36 -34 -33 -26 -19 -14 -10 -11 -13 -14 -15 -15 -15 -15 -15 -15 -13 -13
Change (%) -2.57 -3.02 -5.32 -20.66 -25.21 -28.68 -29.76 15.43 14.82 8.03 5.92 3.31 1.33 -0.19 -0.96 -2.56 -9.32 -5.75
% of Revenue -30.84 -27.79 -24.54 -21.27 -15.59 -10.80 -7.12 -4.66 -5.03 -5.55 -5.83 -5.98 -6.05 -6.02 -5.95 -5.95 -5.88 -5.43 -5.18
Net Income -53 -49 -51 -57 -52 -50 -40 -28 -7 -11 -14 -182 -202 -200 -405 -364 -413 -511 -305
Change (%) -6.88 4.84 11.36 -9.22 -3.67 -19.11 -31.58 -73.90 48.21 28.77 1,222.48 11.03 -1.26 102.62 -10.03 13.41 23.65 -40.34
% of Revenue -44.46 -38.28 -36.55 -37.25 -31.24 -27.88 -20.84 -13.28 -3.24 -4.62 -5.79 -74.08 -80.50 -78.16 -156.65 -142.38 -163.81 -206.05 -124.43

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista